MSD Animal Health announces new webinar

News
Article

The division of Merck & Co, Inc will virtually host a webinar dedicated to educating attendees on the One Health approach to vector-borne diseases

sweetcrisis / stock.adobe.com

sweetcrisis / stock.adobe.com

MSD Animal Health, a division of Merck & Co, Inc, will host a live virtual event featuring experts in public health, veterinary medicine, and parasitology. The experts will share their perspectives on managing the threat of vector-borne diseases.

This virtual event will feature:

  • Overview of the One Health approach with Jane Sykes, PhD, BVSc, UC Davis School of Veterinary Medicine, and Julie Gerberding, MD, MPH, chief patient officer and executive vice president, population health & sustainability, MSD Animal Health; moderated by Alasdair King, international veterinary health, MSD Animal Health (10:00-10:45 am ET)
  • Panel discussion on VBDs as a model for the One Health approach, featuring Peter Irwin, BVetMed, PhD (James Cook), FANZCVS, MRCVS, College of Veterinary Medicine, Murdoch University; Susan Little, DVM, PhD, DACVM (Parasit.), Center for Veterinary Health Sciences, Oklahoma State University; Guadalupe Miró, DVM, PhD, Dipl. EVPC, Parasitology and Parasitic Diseases, Universidad Complutense of Madrid; Paul Overgaauw, DVM, PhD, Dipl. ACVM, Veterinary Public Health, Utrecht University; and Richard Wall, BSc, MBA, PhD, School of Biological Sciences, University of Bristol (10:45-11:45 am ET)
  • New data and insights on pet owner compliance with current parasite treatment recommendations and keeping pets who live in our homes free from VBDs, by Dr. Robert Lavan, MPVM, DVM, Director, Center for Observational and Real-World Evidence, MSD Animal Health (11:45 am-12:15 pm ET)

Registrants will also receive access to additional free webinars from “leading experts on some of the most prevalent vector-borne diseases found today,” according to the release.1

This event is approved through the American Association of Veterinary State Board’s Registry of Approved Continuing Education (RACE) for 2.5 hours and hosted through the Webinar Vets platform.

“Many external factors impacting society have contributed to spread of vector borne diseases, making the One Health approach more important now than ever,” said Fernando Riaza Carcamo, vice president, global marketing, MSD Animal Health. “Our company is committed to improving the health of people and animals that share our complex and ever-changing environment through the discovery and development of preventative solutions for existing and emerging diseases.”

According to the World Health Organization, vector-borne diseases account for an estimated 17% of the global burden of all infectious diseases.2 In addition, the Centers for Disease Control and Prevention states that 60% of known infectious diseases in people can be spread from animals—through direct or indirect contact, vectors, food, and water.3 Research has shown that 75% of new or emerging infectious diseases in people come from animals.4

The event will take place on Wednesday, March 2, 2022. and those interested in attending can register here.

References

  1. MSD Animal Health hosts: A One Health Approach to Vector-Borne Diseases. News Release. MSD Animal Health. January 21, 2022. Accessed February 23, 2022. https://www.msd-animal-health.com/2022/01/21/msd-animal-health-hosts-a-one-health-approach-to-vector-borne-diseases/
  2. Vector-borne diseases. WHO. March 2, 2020. Accessed February 23, 2022. https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases#:~:text=Vector%2Dborne%20diseases%20account%20for,infection%20transmitted%20by%20Anopheline%20mosquitoes.
  3. Zoonotic diseases. CDC. Accessed February 23, 2022. https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html
  4. Gebreyes WA, Dupouy-Camet J, Newport MJ, et al. The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings. PLoS Negl Trop Dis. 2014;8(11):e3257. Published 2014 Nov 13. doi:10.1371/journal.pntd.0003257
Related Videos
© 2024 MJH Life Sciences

All rights reserved.